PS Georgoulia, S Bjelic, R Friedman - The FEBS journal, 2020 - pubmed.ncbi.nlm.nih.gov
FMS-like tyrosine kinase 3 (FLT3) has been found to be mutated in~ 30% of acute myeloid
leukaemia patients. Small-molecule inhibitors targeting FLT3 that are currently approved or …